Tests a team-based care approach for adults with type 2 diabetes
Tests a team-based care program in clinics for adults with type 2 diabetes.
Key facts
- Who runs it
- Stanford University
- Where
- Boston, Columbus, and Stanford, United StatesSee the 3 sitesAlso in 1 other country, 1 site
- Trial code
- Registry title
- Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- Status
- Recruiting
- People taking part
- 119,680 people, planned
- Started
- 30 Sept 2025
- Expected to end
- 31 Jan 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- iPATH implementation approach
- Record updated
- 1 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for community health centers (FQHCs) in or near Massachusetts, Ohio, California and Puerto Rico. They will adopt a team-based, technology-enabled model of care for adults with type 2 diabetes.
- Age
- 18 Years or older
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes. The trial prioritizes health centers in the lower half for blood sugar (A1c) control.
Main reasons for not taking part
- Health centers where more than 80% of patients are children
- Health centers with fewer than 5,000 or more than 50,000 patients
- Health centers in the lowest 10% for patient population multiplied by diabetes prevalence
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Two largest clinic sites in multi-clinic FQHCs operating in or near Massachusetts, Ohio, California, Puerto Rico
- We will prioritize FQHCs performing in the lower half of the distribution for A1c control, as these FQHCs have greater room for improvement
Who cannot take part
- FQHCs that have a patient population multiplied by the FQHC's diabetes prevalence in the lowest 10% of all the clinics
- FQHCs that have a patient population comprised of more than 80% children
- FQHCs that have fewer than 5,000 or more than 50,000 patients
Where in United States
Also in 1 other country, 1 site
- President and Fellows of Harvard College, T.H. Chan SchoolBoston, United StatesContact: Michaela Kerrissey, PhDTaking people
- The Ohio State UniversityColumbus, United StatesContact: Daniel Walker, PhDTaking people
- Board of Trustees of the Leland Stanford Junior UniversityStanford, United StatesContact: Sara Singer, PhDTaking people
About the trial
What the trial wants to find out
Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in qualitative interviews. Patient HbA1c data from the clinics will be collected for comparative data analysis during each year of the study.
The 2 groups in the trial
- Wave 1 ClinicsTreatment being tested
Clinics will have data evaluated for up to 3 years. Wave 1 clinics will begin the iPATH practice transformation in Year 1.
Treatment: iPATH implementation approach
- Wave 2 ClinicsTreatment being tested
Clinics will have data evaluated for up to 3 years. Wave 2 clinics will begin the iPATH practice transformation in Year 2.
Treatment: iPATH implementation approach
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
- Plain-language title
- Tests a team-based care approach for adults with type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 1 May 2026